Safety pen needle assemblies are known in the prior art for shielding a used needle post-injection. Such assemblies may be generally classified as “passive” or “active”. A passive device is typically considered to be one where shielding may be achieved without requiring additional steps beyond that required to conduct an injection. In contrast, an active device is typically considered to be one where shielding requires one or more additional steps beyond that required to conduct an injection, such as, for example, triggering a spring-fired shield.
In addition, shielding is most commonly utilized with the distal, patient end of the needle. Shielding has been also provided for the proximal, non-patient end of the needle and has been provided on the same device for both the distal and proximal ends of the needle post-injection. U.S. Pat. No. 7,540,858 to DiBiasi and U.S. Published Patent Application No. 2011/0178473 A1 to Richards et al., both to the assignee herein, show passive dual end shielding safety pen needle assemblies where both the distal and proximal ends of the needle may be shielded passively post-injection.
In a first aspect, a safety pen needle assembly is provided herein which includes a hub having a proximal end and a distal end, and a needle fixed to the hub, the needle having a distal end, formed for insertion into a patient, and a proximal end. The needle extends distally from the distal end of the hub so as to define an injection length of the needle between the distal end of the needle and the distal end of the hub. The assembly further includes a first shield slidable relative to the hub from a first state, in which, the shield covers at least a substantial portion of the injection length of the needle, to a second state, in which at least a substantial portion of the injection length of the needle is exposed. Further, a second shield is provided slidable relative to the hub from a first position, in which the shield covers the proximal end of the needle, to a second position, in which the proximal end of the needle is exposed. A biasing element is disposed between the first and second shields configured to simultaneously generate a biasing force configured to urge the first shield distally towards the first state and to generate a biasing force configured to urge the second shield proximally towards the first position. Advantageously, a passive safety pen needle assembly may be formed which requires a minimal number of parts.
In a further aspect, a safety pen needle assembly is provided utilizing only the patient end shield of the subject invention.
These and other features of the invention will be better understood through a study of the following detailed description and accompanying drawings.
With reference to
As used herein the term “distal”, and derivatives thereof, refer to a direction generally towards a patient, while the term “proximal”, and derivatives thereof, generally refer to a direction away from a patient.
With specific reference to
Mounting feature 38 may be defined on the interior of the outer wall 22 in proximity to the proximal end 24. The mounting feature 38 may be any known feature usable for mounting the safety pen needle assembly 10 onto a medical injector, such as a thread, bayonet-lock feature, a surface configuration (e.g., a tapered or Luer surface) and so forth. The cross-piece 30 is preferably located distally of the mounting feature 38.
At least one guide slot 40 is formed in the outer wall 22 in proximity to the distal end 26. In addition, at least one locking aperture 42 is provided in proximity to each guide slot 40. It is further preferred that at least one channel 44 be located in the outer wall 22 distally of the cross-piece 30. Further, at least one retention aperture 46 is preferably formed in the outer wall 22 distally of the cross-piece 30.
The needle 14 includes a distal end 48, which is formed for insertion into a patient, and a proximal end 50. The needle 14 is fixed inside the passage 34, using any known technique, such as with adhesive, fusion, etc., so that the distal end 48 of the needle 14 is located distally of the distal end 26 of the hub 12, so as to define an injection length I (
With reference to
The first shield 16 is provided with at least one guide protrusion 64. The guide protrusion 64 is formed to be seatingly received within the guide slot 40. Portions of the body 52 about the guide protrusion 64 may be removed so as to define a cantilevered arm 66 on which the guide protrusion 64 is located. In addition, at least one locking tab 68 is provided on the first shield 16 configured to be snap engaged in the locking aperture 42. It is preferred that the body 52 provide sufficient resilience to maintain snap engagement with the locking tab 68 received in the locking aperture 42. To this end, the constituent material of the body 52 may provide such resiliency. In addition, or alternatively, the locking tab 68 may be located on cantilevered locking arm 70. As best shown at
With reference to
The biasing element 20 is preferably a single component, such as a spring, e.g., a coil or a compression spring. The biasing element 20, as shown in
The biasing element 20 is configured to simultaneously generate biasing force configured to distally urge the first shield 16 and to proximally urge the second shield 18.
In an initial state, as shown in
As shown in
It is noted that the first shield 16 may be caused to cover the distal end 48 of the needle. As shown in the Figures, a rotatable skin engagement member 96 may be provided such as that disclosed in U.S. Published Patent Application No. 2012/0046614 A1, which is incorporated by reference herein. As shown in
In addition, in an initial state, as shown in
Upon removal of the safety pen needle assembly 10 from a medical injector, the biasing element 20 urges the second shield 18 proximally towards a shielding state. The enlarged portion 80 slides along the channel 44 during such movement. The second shield 18 may be configured to engage the cross-piece 30 to limit proximal movement of the second shield 18 coincident with the shielding state in which the second shield 18 covers the proximal end 50 of the needle 14. In the shielding state, the locking detent 84 may be positioned to be snap engaged in the retention aperture 46 so as to inhibit further distal movement of the second shield 18 relative to the hub 12.
A secondary retention aperture 100 may be provided to receive the locking detent 84 in snap engagement during use. Preferably, this snap engagement is overcome by the force of the biasing element 20, particularly with the biasing element being compressed during use by the distal retraction of second shield 18 relative to the hub 12. The compressive force of the biasing element 20 may be further increased due to the proximal retraction of the first shield 16 relative to the hub 12 during use.
As will be appreciated by those skilled in the art, advantageously, the biasing element 20, acting alone, may be used with the subject invention to passively cause shielding of both the distal and proximal ends 48, 50 of the needle 14. This allows for a minimal number of parts to be used to provide a passive safety pen needle assembly capable of shielding both ends of a needle.
As a further variation of the subject invention, and with reference to
This application claims priority to U.S. Provisional Patent Application No. 61/914,306, filed Dec. 10, 2013, the entire contents of which are hereby incorporated by reference.
Number | Name | Date | Kind |
---|---|---|---|
4894055 | Sudnak | Jan 1990 | A |
4897083 | Martell | Jan 1990 | A |
4998924 | Ranford | Mar 1991 | A |
5061246 | Anapliotis | Oct 1991 | A |
5193552 | Columbus et al. | Mar 1993 | A |
5246428 | Falknor | Sep 1993 | A |
5250037 | Bitdinger | Oct 1993 | A |
5256153 | Hake | Oct 1993 | A |
5269765 | Kuracina | Dec 1993 | A |
5279579 | D'Amico | Jan 1994 | A |
5292314 | D'Alessio et al. | Mar 1994 | A |
5336197 | Kuracina et al. | Aug 1994 | A |
5364362 | Schulz | Nov 1994 | A |
5389085 | D'Alessio et al. | Feb 1995 | A |
5417662 | Hjertman et al. | May 1995 | A |
5429612 | Berthier | Jul 1995 | A |
5514097 | Knauer | May 1996 | A |
5562624 | Righi et al. | Oct 1996 | A |
5591138 | Vaillancourt | Jan 1997 | A |
5609577 | Haber et al. | Mar 1997 | A |
5634906 | Haber et al. | Jun 1997 | A |
5688241 | Asbaghi | Nov 1997 | A |
5795336 | Romano et al. | Aug 1998 | A |
5810775 | Shaw | Sep 1998 | A |
5873856 | Hjertman et al. | Feb 1999 | A |
5971966 | Lav | Oct 1999 | A |
RE36398 | Byrne et al. | Nov 1999 | E |
5984899 | D'Alessio et al. | Nov 1999 | A |
RE36447 | Byrne et al. | Dec 1999 | E |
6017329 | Hake | Jan 2000 | A |
6110147 | Perouse | Aug 2000 | A |
6203529 | Gabriel et al. | Mar 2001 | B1 |
6224576 | Thorne et al. | May 2001 | B1 |
6379336 | Asbaghi et al. | Apr 2002 | B1 |
6547764 | Larsen et al. | Apr 2003 | B2 |
6569124 | Perouse | May 2003 | B1 |
6692463 | Marteau et al. | Feb 2004 | B1 |
6773415 | Heiniger | Aug 2004 | B2 |
6796967 | Jensen | Sep 2004 | B2 |
6855129 | Jensen et al. | Feb 2005 | B2 |
6939330 | McConnell-Montalvo et al. | Sep 2005 | B1 |
6986760 | Giambattista et al. | Jan 2006 | B2 |
7066907 | Crossman et al. | Jun 2006 | B2 |
7074211 | Heiniger et al. | Jul 2006 | B1 |
7147624 | Hirsiger et al. | Dec 2006 | B2 |
7198617 | Millerd | Apr 2007 | B2 |
7229432 | Marshall et al. | Jun 2007 | B2 |
7278986 | Frost | Oct 2007 | B1 |
7361160 | Hommann et al. | Apr 2008 | B2 |
7361166 | Bosse et al. | Apr 2008 | B2 |
7370759 | Hommann | May 2008 | B2 |
7374558 | Kirchhofer | May 2008 | B2 |
7384414 | Marshall et al. | Jun 2008 | B1 |
7442185 | Amark et al. | Oct 2008 | B2 |
7540858 | DiBiasi | Jun 2009 | B2 |
7635350 | Scherer | Dec 2009 | B2 |
8177745 | Brechbuehler et al. | May 2012 | B2 |
20020193746 | Chevallier | Dec 2002 | A1 |
20030014018 | Giambattista et al. | Jan 2003 | A1 |
20030120209 | Jensen et al. | Jun 2003 | A1 |
20040122379 | Bosse et al. | Jun 2004 | A1 |
20050113750 | Targell | May 2005 | A1 |
20050267410 | Koska | Dec 2005 | A1 |
20050277893 | Liversidge | Dec 2005 | A1 |
20050288607 | Konrad | Dec 2005 | A1 |
20060095010 | Westbye | May 2006 | A1 |
20060270984 | Hommann | Nov 2006 | A1 |
20070027430 | Hommann | Feb 2007 | A1 |
20070129674 | Liversidge | Jun 2007 | A1 |
20070156101 | Liversidge | Jul 2007 | A1 |
20070173772 | Liversidge | Jul 2007 | A1 |
20070255225 | Alchas et al. | Nov 2007 | A1 |
20080009807 | Hommann | Jan 2008 | A1 |
20080071225 | Hommann et al. | Mar 2008 | A1 |
20080077093 | Gratwohl et al. | Mar 2008 | A1 |
20080103453 | Liversidge | May 2008 | A1 |
20080103454 | Gratwohl et al. | May 2008 | A1 |
20080177237 | Stonehouse et al. | Jul 2008 | A1 |
20080249477 | Paproski et al. | Oct 2008 | A1 |
20080255526 | Bosse et al. | Oct 2008 | A1 |
20080262436 | Olson | Oct 2008 | A1 |
20080269691 | Cowe | Oct 2008 | A1 |
20090005742 | Liversidge | Jan 2009 | A1 |
20090221972 | Gratwohl et al. | Sep 2009 | A1 |
20090254042 | Gratwohl | Oct 2009 | A1 |
20090259178 | Bechbuehler et al. | Oct 2009 | A1 |
20090259196 | Gratwohl et al. | Oct 2009 | A1 |
20100114035 | Schubert et al. | May 2010 | A1 |
20110178473 | Richards et al. | Jul 2011 | A1 |
20110257603 | Ruan et al. | Oct 2011 | A1 |
Number | Date | Country |
---|---|---|
8909799 | Nov 1989 | DE |
102006022081 | Jan 2008 | DE |
102006041810 | Mar 2008 | DE |
1464353 | Oct 2004 | EP |
1747789 | Jan 2007 | EP |
2881053 | Jul 2006 | FR |
9002515 | Mar 1990 | WO |
9209319 | Jun 1992 | WO |
9220281 | Nov 1992 | WO |
0191837 | Dec 2001 | WO |
0193924 | Dec 2001 | WO |
03045480 | Jun 2003 | WO |
03105935 | Dec 2003 | WO |
2004000397 | Dec 2003 | WO |
2004030539 | Apr 2004 | WO |
2004071560 | Aug 2004 | WO |
2005097238 | Oct 2005 | WO |
2006018626 | Feb 2006 | WO |
2006072807 | Jul 2006 | WO |
2007077463 | Jul 2007 | WO |
2008025179 | Mar 2008 | WO |
2008028304 | Mar 2008 | WO |
2008028305 | Mar 2008 | WO |
2008028312 | Mar 2008 | WO |
2008035122 | Mar 2008 | WO |
2008043188 | Apr 2008 | WO |
2008044067 | Apr 2008 | WO |
2008050158 | May 2008 | WO |
2008083037 | Jul 2008 | WO |
2009003300 | Jan 2009 | WO |
2009030056 | Mar 2009 | WO |
WO-2009102612 | Aug 2009 | WO |
2009114762 | Sep 2009 | WO |
2010126432 | Nov 2010 | WO |
Entry |
---|
Clickfine® AutoProtect™; YPSOMED Selfcare Solutions; www.ypsomed.com/b2b@ypsomed.com. |
Number | Date | Country | |
---|---|---|---|
20150157808 A1 | Jun 2015 | US |
Number | Date | Country | |
---|---|---|---|
61914306 | Dec 2013 | US |